Effect of Treatment with Dornase Alpha on Airway Inflammation in Patients with Cystic Fibrosis-Reference-Cited by-同舟云学术

Effect of Treatment with Dornase Alpha on Airway Inflammation in Patients with Cystic Fibrosis

Published:2004-03-15 Issue:6 Volume:169 Page:719-725
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Paul Karl,Rietschel Ernst,Ballmann Manfred,Griese Matthias,Worlitzsch Dieter,Shute Janis,Chen Christiane,Schink Tanja,Döring Gerd,van Koningsbruggen Silke,Wahn Ulrich,Ratjen Felix

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference38 articles.

1. Evidence for Periciliary Liquid Layer Depletion, Not Abnormal Ion Composition, in the Pathogenesis of Cystic Fibrosis Airways Disease

2. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, Birrer P, Bellon G, Berger J, Weiss T,et al.Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients.J Clin Invest2002;109:317–325.

3. Current understanding of the inflammatory process in cystic fibrosis: Onset and etiology

4. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line.

5. Mechanisms and markers of airway inflammation in cystic fibrosis: Fig. 1.—

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The continuing need for dornase alfa for extracellular airway DNA hydrolysis in the era of CFTR modulators;Expert Review of Respiratory Medicine;2024-08-30

2. Pseudomonas aeruginosa in chronic lung disease: untangling the dysregulated host immune response;Frontiers in Immunology;2024-06-28

3. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis;Cochrane Database of Systematic Reviews;2024-05-03

4. Geschichtlicher Abriss der Mukoviszidose;Monatsschrift Kinderheilkunde;2024-04-19

5. Recombinant Human Deoxyribonuclease I;Pharmaceutical Biotechnology;2024